IJAMSC  Vol.3 No.2 , June 2015
Analytical Methods in the Quality Control of Scientific Publications Part V: The Fraud of Pseudoscientists Based on False Measurements and Method Development
Author(s) Ilia Brondz
ABSTRACT
Despite the obvious frauds published in [1] [2] and the involvement of Editors and Editors in Chief of the journals in the publication of these fraudulent papers, the Editors in Chief of publishers have not taken any action to retract the fraudulent papers or to dismiss the corrupt editors. By this passivity, these Editors in Chief are supporting plagiarism, dissemination of fraudulent data, lies and making published information unreliable. In the present paper, we evaluate examples of bold, fraudulent publications and give the names of some Editors directly participating in concealing fraudulent publications, together with the names of Editors in Chief who also concealed and covered the facts of fraud and were reluctant to remove the fraudulent papers from circulation or to remove cheaters from editorial positions. The truth is universal and international; in contrast, the lie is individual and partisan, social, political, confessional, cultural and dirty. Knowledge is a truth that is part of the Universe. Lies are a tool of manipulation and can exist only in distinct environments that produce and support them. In this paper, we will show how artificial prefabricated analytical procedures were used to disseminate false data with the aim of substituting the truth with fraud.

Cite this paper
Brondz, I. (2015) Analytical Methods in the Quality Control of Scientific Publications Part V: The Fraud of Pseudoscientists Based on False Measurements and Method Development. International Journal of Analytical Mass Spectrometry and Chromatography, 3, 25-31. doi: 10.4236/ijamsc.2015.32003.
References
[1]   Dongre, V.G., Karmuse, P.P., Nimbalkar, M.M., Singh, D. and Kumar, A. (2005) Applications of GC-EI-MS for the Identification and Investigation of Positional Isomer in Primaquine, an Antimalarial Drug. Journal of Pharmaceutical and Biomedical Analysis, 39, 111-116.
http://dx.doi.org/10.1016/j.jpba.2005.03.019

[2]   Elbashir, A.A., Saad, B., Ali, A.S.M., Saleha, M.I. and Aboul-Enein, H.Y. (2009) Determination of Quinocide as Impurity in Primaquine Tablets by Capillary Zone Electrophoresis. Biomedical Chromatography, 23, 464-471. http://dx.doi.org/10.1002/bmc.1137

[3]   Brondz, I., Mantzeilas, D., Klein, U., Lebedeva, M.N., Mikhailitsyn, F.S., Souleimanov, G.D. and Ekeberg, D. (2003) The Main Contaminant of the Anti-Malaria Drug Primaquine Is Its Positional Isomer. 3rd International Symposium on Separation in BioSciences SBS 2003 A 100 Years of Chromatography, Moscow, 13-18 May 2003, Abstract P-57, 165.

[4]   Schmidt, L.H., Alexander, S., Allen, L. and Rasco, J. (1977) Comparison of the Curative Antimalarial Activities and Toxicities of Primaquine and Its d- and l-Isomers. Antimicrobial Agents Chemotherapy, 12, 51-60. http://dx.doi.org/10.1128/AAC.12.1.51

[5]   Baker, J.K., Yarber, R.H., Nanayakkare, N.P.D., McChesney, J.D., Homo, F. and Landau, I. (1990) Effects of Aliphatic Side-Chain Substituents on the Antimalarial Activity and on the Metabolism of Primaquine Studied Using Mitochondria and Microsome Preparations. Pharmacological Research, 7, 91-95. http://dx.doi.org/10.1023/A:1015899928897

[6]   Saunders, D., Vanachayangkul, P., Imerbsin, R., Khemawoot, P., Siripokasupkul, R., Tekwani, B.L., Sampath, A., Nanayakkara, N.P.D., Ohrt, C., Lanteri, C., Gettyacamin, M., Teja-Isavadharm, P. and Walker, L. (2014) Pharmacokinetics and Pharmacodynamics of (+)-Primaquine and (-)-Primaquine Enantiomers in Rhesus Macaques (Macacamulatta). Antimicrobial Agents Chemotherapy, 58, 7283-7291. http://dx.doi.org/10.1128/AAC.02576-13

[7]   Brondz, I., Mantzilas, D., Klein, U., Ekeberg, D., Hvattum, E., Lebedeva, M.N., Mikhailitsyn, F.S., Souleimanov, G.D. and RΦe, J. (2004) Nature of the Main Contaminant in the Anti-Malaria Drug Primaquine Di-Phosphate: A Qualitative Isomer Analysis. Chromatography B: Biomedical Sciences and Applications, 800, 211-223. http://dx.doi.org/10.1016/j.jchromb.2003.09.042

[8]   Brondz, I. (2011) Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine. Nova Science Publishers, Inc., New York.

[9]   (1988) British Pharmacopoeia. Vol. I, HMSO, London, 462.

[10]   (1988) British Pharmacopoeia. London, HMSO. (Addendum, 1990, 1252)

[11]   Brondz, I. (2014) Review: Can Toxic Substances Initiate Psychotic Behavior? Part I. Anti-Malarial Drugs. Open Journal of Preventive Medicine, 4, 561-572. http://dx.doi.org/10.4236/ojpm.2014.47066

[12]   (1993) British Pharmacopoeia, Vol. I, London, HMSO, 2015. (Addendum, 1997)

[13]   (1997) European Pharmacopoeia. 3rd Edition, Council of Europe, Strasbourg, 1385.

[14]   (2000) British Pharmacopoeia, Vol. I, London, HMSO, 1285.

[15]   (2001) European Pharmacopoeia. 3rd Edition, Council of Europe, Strasbourg, 1323. (Supplement)

[16]   (2008) The United States Pharmacopeia, 31 Revision and The National Formulary. 26th Edition, Vol. 3, The United States Pharmacopeia Convention, Rockville.

[17]   Brondz, I., Klein, U., Ekeberg, D., Mantzilas, D., Hvattum, E., Schultz, H. and Mikhailitsyn, F.S. (2004) Nature of the Main Contaminant in the Anti-Malaria Drug Primaquine Di-Phosphate: GC-MS Analysis. International Symposium Analytical Forum 2004, Warsaw, 4-8 July 2004, 119, 154.

[18]   Brondz, I., Klein, U., Ekeberg, D., Mantzilas, D., Hvattum, E., Schultz, H. and Mikhailitsyn, F.S. (2005) Nature of the Main Contaminant in the Anti-Malaria Drug Primaquine Di-Phosphate: GC-MS Analysis. Asian Journal of Chemistry, 17, 1678-1688.

[19]   Brondz, I. and Klein, U. (2005) Separation of the Positional Isomer Quinocide from the Anti-Malarial Drug Primaquine Using a Discovery? HS F5 HPLC Column. The Reporter, 23, 1.

[20]   Brondz, I., Ekeberg, D., Karaliova, L., Jennings, I., Hustad, J.A. and Svendsen, R. (2005) Separation of the Positional Isomer Quinocide from the Anti-Malaria Drug Primaquine Using a Discovery? HS-F5 HPLC Column. Trends in Chromatography, 1, 78-81.

[21]   Brondz, I., Klein, U., Karaliova, L., Vlachos, V., Oakley, P., Leideborg, R. and Mikhalitsyn, F. (2005) Nature of the Main Contaminant in the Drug Primaquine Di-Phosphate: Comparison of HPLC and SFC Methods. 29th International Symposium on High Performance Liquid Phase Separations and Related Techniques, Stockholm, 26-30 June 2005, 430.

[22]   Brondz,I. Ekeberg,D. Annino, A. R. Palcic,T. (2007), SFC-MS Analyses of Anti-Malaria Drug Primaquine Diphosphate. Comparison of Techniques and Instrumentation. 12th Norwegian MS-Winter Meeting, Hafjell, 21-24 January 2007, 42.

[23]   Brondz, I., Ekeberg, D., Bell, D.S., Hustad, J.A., Svendsen, R., Vlachos, V., Oakley, P., Langley, G.J., Mohini, T., Amaury, C.-G. and Mikhalitsyn, F. (2007) Nature of the Main Contaminant in the Drug Primaquine Diphosphate: SFC and SFC-MS Methods of Analysis. Journal of Pharmaceutical and Biomedical Analysis, 43, 937-944. ttp://dx.doi.org/10.1016/j.jpba.2006.09.017

[24]   Brondz, I. (2009) SFC-MS Analysis of Contaminants in Primaquine Diphosphate Tablets and Spectral UV and NMR Characterizing of Primaquine and Quinocide. 5th Conference of Nordic Separation Science Society, Tallinn, 26-29 August 2009, Abstract PP07.

[25]   Brondz, I. Fialkov, A.B. and Amirav, A. (2009) Analysis of Quinocide in Unprocessed Primaquine Diphosphate and Primaquine Diphosphate Tablets Using Gas Chromatography-Mass Spectrometry with Supersonic Molecular Beams. J. Chromatography A, 1216, 824-829.
http://dx.doi.org/10.1016/j.chroma.2008.11.043

[26]   Brondz, I. (2011) In Vitro Techniques in Analysis of Antimalarial Drug Primaquine (Historical Overview of Chromatography and Related Techniques in Analysis of Antimalarial Drug Primaquine). 7th Annual BioMalPar Conference on the Biology and Pathology of the Malaria Parasite, Heidelberg, 16-18 May 2011, 80.

[27]   ElBashir, A.A., Saad, B., Ali, A.S.M., Saleha, M.I. and Aboul-Enein, H.Y. (2009) Enantioselective Analysis of Primaquine and Its Impurity Quinocide by Capillary Electrophoresis. Biomedical Chromatography, 23, 295-301. http://dx.doi.org/10.1002/bmc.1113

[28]   Altigani, A.M.N. and Elbashir, A.A. (2014) Spectrophotometric Method for Determination of Primaquine in Pharmaceutical Formulations via Derivatization with 1,2-Naphthoquinone-4-Sulfonate. Austin Journal of Analytical and Pharmaceutical Chemistry, 1, 1019.

[29]   Brondz, I. (2014) Analytical Methods in Quality Control of Scientific Publications Part IV: Fraud Ordered by the Pharmaceutical Industry. International Journal of Analytical Mass Spectrometry and Chromatography, 2, 103-112. http://dx.doi.org/10.4236/ijamsc.2014.24009

[30]   Luk’yanchikova, G.I., Bernshtein, V.N. and Prokoshev, A.A. (1970) Quantitative Determination of Quinocide and Quinosol. Farmatsiya, 19, 84.

[31]   Abdel, S.M. Issa, A.S. and Lymona, H. (1986) Utility of the Charge-Transfer Complex Formation for the Spectrophotometric Determination of Some Antimalarials. Journal de Pharmacie de Belgique, 41, 314-318.

[32]   Sasty, B.S., Rao, E.V., Tumuru, M.K. and Sastry, C.S.P. (1986) A New Spectrophotometric Method for the Estimation of Primaquine Using MBTH. Indian Journal of Pharmaceutical Sciences, 48, 190-192.

[33]   Rao, R.G., Murty, S.S.N. and Raju, I.R.K. (1988) Spectrophotometric Determination of Primaquine Phosphate with Ninhydrin. Indian Drugs, 26, 86-88.

[34]   Sasty, B.S., Rao, E.V., Tumuru, M.K. and Sastry, C.S.P. (1989) Estimation of Primaquine in Its Formulations. Indian Drugs, 27, 260-261.

[35]   Amin, A.S. and Issa, Y.M. (2000) Spectrophotometric Microdetermination of Some Pharmaceutically Important Aminoquinoline Antimalarials, as Ion-Pair Complexes. Microchimica Acta, 134, 133-138.
http://dx.doi.org/10.1007/s006040070028

 
 
Top